bioAffinity Technologies, Inc. (BIAFW) Free cash flow 2022–2025
bioAffinity Technologies, Inc. (BIAFW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$9.4MFY2025 · since FY2022: -$4.3M → -$9.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.4M | -27.9% |
| FY2024 | -$7.3M | -21.2% |
| FY2023 | -$6.1M | -41.2% |
| FY2022 | -$4.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice